Office of Technology Transfer – University of Michigan

CD44 shRNA OSCC and Vector Control Cells

Technology #4956

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Yvonne Kapila
Managed By
Anne Juggernauth
Licensing and Market Specialist 734-936-9749


This is a research tool available for a materials license or material transfer agreement.


Researchers have developed an oral squamous cell carcinoma (OSCC) cell line that has stably suppressed levels of CD44 (UMSCC14A) and its vector control.